Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib vs tofacitinib for multiple keloids
ChiCTR2100045205Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in keloid comparing Tofacitinib group with Baricitinib group (2 arms). Primary endpoints: Vancouver Scar Scale, Patient and Observer Scar Assessment Scale and 1 more. Started Jan 2021; status: recruiting.
02
Drugs
baricitinibtofacitinib
03
Conditions
keloid
Beyond the preview
Go deeper on ChiCTR2100045205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045205.